Angiodynamics (ANGO) Free Cash Flow Growth (3y) (2013 - 2026)
Angiodynamics (ANGO) Free Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 65.83% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 414.89% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 27.06% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.44% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 23.97% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -3.97% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -37.68% |
| 10 | Angiodynamics | 505.81 Mn | 468.00 Mn | 41.48 Mn | -243.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -243.75% |
| Nov 30, 2025 | -12.30% |
| Aug 31, 2025 | 14.86% |
| May 31, 2025 | 12.08% |
| Feb 28, 2025 | 1.69% |
| Nov 30, 2024 | 10.34% |
| Aug 31, 2024 | -24.91% |
| May 31, 2024 | -27.38% |
| Feb 29, 2024 | -68.43% |
| Nov 30, 2023 | -26.22% |
| Aug 31, 2023 | -54.42% |
| May 31, 2023 | 92.26% |
| Feb 28, 2023 | 82.22% |
| Nov 30, 2022 | 23.77% |
| Aug 31, 2022 | -50.42% |
| May 31, 2022 | -18.83% |
| Feb 28, 2022 | -59.46% |
| Nov 30, 2021 | -59.54% |
| Aug 31, 2021 | -1.27% |
| May 31, 2021 | -20.48% |